Ann: Quarterly Activities Report, page-81

First 81 Last

Share
Profile

Follow
glendronach

944 Posts.

579

04/05/21

15:56

Post #: 52929555
Share

Originally posted by glendronach: ↑

"LT holders are still here because we invested before it was even mentioned. For me ceramics and hpa followed by nanotechnology will be cashcows." Absolutely correct. HPA is the big sleeper. Nano going to take time. They are in that horrible period when you dont know what should really come first. Most of my other mineral/metals tell me you need mining licence before you get to BOA and consequently committed funding. And you cant get viable de-risked funding until you get some meaningful BOA. We need that ML. But they say ML will come some time later in year. Once we get ML everything fits into place. BOOM! Covid has been a significant challenge.

I hate to say we got some ongoing uncontrollable issues happening at wrong time. At the end of last year there were amendments to the SA Mining Act resulting substantial changes to land access arrangements - significant regulatory reform. My well informed/connected SA mate tells me indep MPs and opposition have combined to pass a private members bill to establish a parliamentary select committee enquiry into land access for mining and petroleum. We dont know the exact timing of this. I have found out from another investment industry body SACOME is on to it saying its totally unnecessary as increased reporting, compliance and engagement measures for operators have happened thru the revisions to the Mining Act. So god knows what the implications are - even after you get the ML approved! Just more and more bloody hoops to jump thru. RioTinto have a lot to answer for.

I am sure JM is on to this and response has been incorporated into the ML submission. It was amazingly detailed. I know there has been lots of engagement happening. Even flying around landowners in flash looking expensive to hire helicopters!

Maybe there are some local SA punters who have more direct knowledge.

Expand

https://www.stockjournal.com.au/story/7162523/land-access-for-mining-under-select-microscope/

Not due to report until Nov. So hopefully will not delay our ML approval. Another nasty fall today. Wots' going on!

ADN Price at posting: 19.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

HAS

Hastings progressing Yangibana to production with lower costs

The iron ore comeback: Can it last?

ZNC

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 1 more message in this thread...

First 81 Last

Add ADN (ASX) to my watchlist

(20min delay)
Last 0.7¢		Change -0.001(12.5%)		Mkt cap ! $23.75M

Open	High	Low	Value	Volume
0.8¢	0.8¢	0.7¢	$14.34K	1.834M

Buyers (Bids)

No.	Vol.	Price($)
76	29116227	0.7¢

Sellers (Offers)

Price($)	Vol.	No.
0.8¢	16375466	25

View Market Depth

No.	Vol.	Price($)
73	27473370	0.007
58	24855155	0.006
27	15930122	0.005
8	10525000	0.004
6	19278333	0.003

Price($)	Vol.	No.
0.008	15375466	24
0.009	14828752	13
0.010	7769819	10
0.011	14346522	7
0.012	13445921	6

Last trade - 15.59pm 30/09/2024 (20 minute delay)

ADN (ASX) Chart

Ann: Quarterly Activities Report, page-81

Hastings progressing Yangibana to production with lower costs

The iron ore comeback: Can it last?

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Quarterly Activities Report, page-81

Top Stories

Hastings progressing Yangibana to production with lower costs

The iron ore comeback: Can it last?

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News